Edwards Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,938	3,045	1,132	769	862.8
Short-Term Investments	1,288	930.7	500.5	446.3	604
Cash & Short-Term Investments	4,226	3,976	1,633	1,215	1,467
Cash Growth	6.30%	143.50%	34.35%	-17.15%	4.58%
Accounts Receivable	659.6	609.1	771.5	643	582.2
Other Receivables	252.5	118.3	56.6	56.1	82.7
Receivables	912.1	727.4	828.1	699.1	664.9
Inventory	1,126	1,087	903.5	875.5	726.7
Prepaid Expenses	135	121	128.8	110	85.2
Restricted Cash	0.5	3.2	3.3	0.5	1.5
Other Current Assets	338.8	371.2	539.2	195.4	235.6
Total Current Assets	6,739	6,285	4,036	3,096	3,181
Property, Plant & Equipment	1,915	1,784	1,675	1,725	1,639
Long-Term Investments	278.6	307.9	583.9	1,239	1,834
Goodwill	1,769	1,777	1,145	1,164	1,168
Other Intangible Assets	1,128	1,177	399.4	285.2	323.6
Long-Term Deferred Tax Assets	1,138	992.1	749.4	484	246.7
Other Long-Term Assets	556.5	603.1	619.2	299.1	110.8
Total Assets	13,697	13,055	9,363	8,293	8,503
Accounts Payable	227.5	197.4	186.6	201.9	204.5
Accrued Expenses	1,065	790.4	667.2	593.1	643.4
Current Portion of Leases	24.5	23.4	22.9	25.5	25.5
Current Income Taxes Payable	192.5	286.6	52.7	50.6	30.6
Current Unearned Revenue	27.2	53.7	-	-	-
Other Current Liabilities	277	153.7	266	151.3	128.3
Total Current Liabilities	1,814	1,505	1,195	1,022	1,032
Long-Term Debt	598.3	597.7	597	596.3	595.7
Long-Term Leases	82.6	78.9	65.2	69.5	69.1
Long-Term Unearned Revenue	10.1	35.1	-	-	-
Pension & Post-Retirement Benefits	28.9	32.1	36.2	23.5	41
Other Long-Term Liabilities	826	743.4	750	774.1	928.6
Total Liabilities	3,360	2,992	2,644	2,486	2,667
Common Stock	658.7	654.8	650.5	646.3	642
Additional Paid-In Capital	2,768	2,613	2,274	1,969	1,700
Retained Earnings	14,241	13,167	8,992	7,590	6,068
Treasury Stock	-7,092	-6,192	-5,025	-4,144	-2,417
Comprehensive Income & Other	-238.3	-244.5	-242.8	-254.9	-157.7
Total Common Equity	10,338	9,998	6,650	5,807	5,836
Minority Interest	-	64.5	69.4	-	-
Shareholders' Equity	10,338	10,063	6,719	5,807	5,836
Total Liabilities & Equity	13,697	13,055	9,363	8,293	8,503
Total Debt	705.4	700	685.1	691.3	690.3
Net Cash (Debt)	3,528	3,281	947.7	524	776.5
Net Cash Growth	7.51%	246.25%	80.86%	-32.52%	9.72%
Net Cash Per Share	6.02	5.48	1.56	0.84	1.23
Filing Date Shares Outstanding	580.4	587.9	601.3	608.31	623.21
Total Common Shares Outstanding	580.4	588.6	601.1	608.3	624.1
Working Capital	4,925	4,780	2,840	2,073	2,148
Book Value Per Share	17.81	16.99	11.06	9.55	9.35
Tangible Book Value	7,441	7,045	5,106	4,357	4,344
Tangible Book Value Per Share	12.82	11.97	8.49	7.16	6.96
Land	152.4	123.9	112.4	116.3	116.5
Buildings	1,393	1,340	1,189	1,189	1,010
Machinery	739.8	689.4	618.6	735	652.6
Construction In Progress	301.2	244	292.5	255.2	333.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.